Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement

NCT07104604 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Liposomal Irinotecan

Sponsor

Affiliated Cancer Hospital of Shantou University Medical College